CN112618637A - Traditional Chinese medicine composition for reducing blood fat and preparation method thereof - Google Patents
Traditional Chinese medicine composition for reducing blood fat and preparation method thereof Download PDFInfo
- Publication number
- CN112618637A CN112618637A CN202011577490.3A CN202011577490A CN112618637A CN 112618637 A CN112618637 A CN 112618637A CN 202011577490 A CN202011577490 A CN 202011577490A CN 112618637 A CN112618637 A CN 112618637A
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- chinese medicine
- medicine composition
- raw material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title claims abstract description 59
- 239000000203 mixture Substances 0.000 title claims abstract description 48
- 239000008280 blood Substances 0.000 title claims abstract description 41
- 210000004369 blood Anatomy 0.000 title claims abstract description 41
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 239000002994 raw material Substances 0.000 claims abstract description 34
- 244000130270 Fagopyrum tataricum Species 0.000 claims abstract description 15
- 235000014693 Fagopyrum tataricum Nutrition 0.000 claims abstract description 15
- 240000002853 Nelumbo nucifera Species 0.000 claims description 19
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 19
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 19
- 235000004347 Perilla Nutrition 0.000 claims description 18
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 17
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 17
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 17
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 17
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 17
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 17
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 17
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 17
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 17
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 17
- 238000001914 filtration Methods 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 238000002791 soaking Methods 0.000 claims description 16
- 235000011201 Ginkgo Nutrition 0.000 claims description 14
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 9
- 238000001035 drying Methods 0.000 claims description 7
- 239000000706 filtrate Substances 0.000 claims description 7
- 150000002632 lipids Chemical class 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 2
- 210000003298 dental enamel Anatomy 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 229910001220 stainless steel Inorganic materials 0.000 claims description 2
- 239000010935 stainless steel Substances 0.000 claims description 2
- 239000006188 syrup Substances 0.000 claims description 2
- 235000020357 syrup Nutrition 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 240000000171 Crataegus monogyna Species 0.000 claims 3
- 244000194101 Ginkgo biloba Species 0.000 claims 3
- 244000124853 Perilla frutescens Species 0.000 claims 3
- 229910052571 earthenware Inorganic materials 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 12
- 210000000952 spleen Anatomy 0.000 abstract description 6
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 4
- 230000002195 synergetic effect Effects 0.000 abstract description 3
- 241000721047 Danaus plexippus Species 0.000 abstract 1
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract 1
- 240000005373 Panax quinquefolius Species 0.000 abstract 1
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 210000002700 urine Anatomy 0.000 abstract 1
- 241000229722 Perilla <angiosperm> Species 0.000 description 15
- 241001092040 Crataegus Species 0.000 description 14
- 239000000047 product Substances 0.000 description 14
- 241000218628 Ginkgo Species 0.000 description 11
- 208000031226 Hyperlipidaemia Diseases 0.000 description 11
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 10
- 230000006872 improvement Effects 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 6
- 238000007873 sieving Methods 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 5
- 235000012000 cholesterol Nutrition 0.000 description 5
- 230000007774 longterm Effects 0.000 description 5
- 230000006378 damage Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 208000001848 dysentery Diseases 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 208000004998 Abdominal Pain Diseases 0.000 description 3
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 201000006549 dyspepsia Diseases 0.000 description 3
- 229940125753 fibrate Drugs 0.000 description 3
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000007721 medicinal effect Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241000049624 Alisma plantago-aquatica subsp. orientale Species 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 241000242722 Cestoda Species 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 208000032928 Dyslipidaemia Diseases 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010038084 Rectocele Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010039020 Rhabdomyolysis Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 239000003524 antilipemic agent Substances 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 229940093797 bioflavonoids Drugs 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 208000018997 giddiness Diseases 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 108010022197 lipoprotein cholesterol Proteins 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000036473 myasthenia Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/535—Perilla (beefsteak plant)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the technical field of traditional Chinese medicines, and discloses a traditional Chinese medicine composition for reducing blood fat and a preparation method thereof, wherein the traditional Chinese medicine composition comprises the following raw material components: the tartary buckwheat, the Chinese yam, the sealwort, the American ginseng, the radix achyranthis bidentatae and the wild artist's conk 6 natural traditional Chinese medicines are reasonably compatible, the monarch, minister, assistant and guide relations among the raw material components are clear, the synergistic effect is good, the effects of nourishing yin, tonifying spleen, tonifying qi and activating blood are ingeniously combined together, the blood sugar and the urine sugar can be stabilized in a normal range for a long time, and the blood fat is effectively reduced.
Description
Technical Field
The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine composition for reducing blood fat and a preparation method thereof.
Background
In recent years, hypertension, hyperglycemia and hyperlipidemia seriously damage the health of modern people. Along with the improvement of living standard, hypertension, hyperlipidemia and hyperglycemia are more and more common, and people suffering from obesity, hypertension and high cholesterol are troubled by bad life rhythms of long-term desk-bending work, lack of exercise and the like. Hyperlipidemia refers to the condition of abnormal fat metabolism or abnormal operation, which makes the blood lipid content in human blood exceed the normal range, and is manifested as high cholesterol and/or triglyceride or low high-density lipoprotein in blood, and is called as "dyslipidemia" in modern medicine. Hyperlipidemia is a common disease, frequently encountered disease, and especially causes the violence of cardiovascular and cerebrovascular diseases, the damage of the disease to the body is secret, gradual, progressive and systemic, and the direct damage of the disease is the acceleration of systemic atherosclerosis. The hyperlipidemia can be prevented and treated, and the long-term lipid regulation treatment can reduce the incidence and mortality of coronary heart disease, angina pectoris, myocardial infarction and cerebral apoplexy, and reduce the disability rate of hyperlipidemia.
At present, the main hypolipidemic drugs for reducing blood fat are: statins and fibrates, and the like. The common western medicine lipid-lowering drugs comprise statins and fibrates, wherein the statins can lower cholesterol and low-density lipoprotein; fibrates of lipid lowering drugs lower triglycerides. However, the western medicines all have certain side effects, for example, some patients have myalgia and myasthenia, some patients are accompanied by muscle ester kinase (CK) rise by more than 10 times, which indicates that the lipid-lowering medicines can cause muscle dissolution, and the medicines all need to be taken by the patients for a long time to have certain curative effect, so that the patients are easy to generate drug resistance, and the side effects of long-term taking are not small and varied.
Disclosure of Invention
The invention provides a traditional Chinese medicine composition for reducing blood fat and a preparation method thereof, which are used for solving one or more technical problems in the prior art and at least providing a beneficial choice or creation condition.
In order to overcome the technical problems, the technical scheme adopted by the invention is as follows:
a traditional Chinese medicine composition comprises the following raw material components: tartary buckwheat, lotus leaves, hawthorn, purple perilla, ginkgo leaves and rhizoma alismatis.
As a further improvement of the scheme, the traditional Chinese medicine composition comprises the following raw material components in parts by weight: 20-40 parts of tartary buckwheat, 5-25 parts of lotus leaves, 5-25 parts of hawthorn, 5-20 parts of purple perilla, 5-10 parts of ginkgo leaves and 8-12 parts of rhizoma alismatis.
As a further improvement of the scheme, the traditional Chinese medicine composition comprises the following raw material components in parts by weight: 25-35 parts of tartary buckwheat, 10-20 parts of lotus leaves, 10-20 parts of hawthorn, 10-15 parts of purple perilla, 6-8 parts of ginkgo leaves and 9-11 parts of rhizoma alismatis.
As a further improvement of the scheme, the dosage form of the traditional Chinese medicine composition is any one of tablets, granules, capsules, pills, oral liquid or syrup.
The preparation method of the traditional Chinese medicine composition comprises the following steps: mixing the raw material components, adding a solvent for soaking, decocting after soaking for 3 times, decocting with strong fire and slow fire, mixing decoctions, filtering, concentrating the filtrate into paste, drying, pulverizing, and sieving to obtain the traditional Chinese medicine composition.
As a further improvement of the above, the solvent is water.
As a further improvement of the proposal, an earthen pot, an enamel pot or a stainless steel pot is selected during the decoction.
As a further improvement of the scheme, the soaking time is 1-2 h.
As a further improvement of the scheme, the duration of the strong fire decoction is 20-40 min; the rest two times of decoction lasts for 30-120 min.
The traditional Chinese medicine composition disclosed by the invention is applied to preparation of a medicine for reducing blood fat.
The Chinese medicinal raw materials used in the invention have the following medicinal properties and effects:
the tartary buckwheat is bitter in nature, flat, mainly comprises bioflavonoids, multiple vitamins, 18 amino acids, crude protein, chlorophyll, selenium, zinc, magnesium, chromium, calcium and other mineral substances and trace elements, has the functions of mainly regulating qi to alleviate pain, tonifying spleen and promoting diuresis, has the functions of treating stomachache, dyspepsia, lumbocrural pain and traumatic injury, can assist in reducing blood fat, and is the best choice for staple food of patients with hyperlipidaemia.
The lotus leaf is bitter, pungent and slightly astringent, and has cold and cool nature and taste, and the lotus leaf enters heart, liver and spleen channels and has faint scent; has effects of removing summer-heat, promoting diuresis, invigorating spleen, invigorating yang, removing blood stasis, and stopping bleeding, and can be used for treating summer-heat polydipsia, headache, giddiness, edema, anorexia, abdominal distention, dysentery, leucorrhea, rectocele, hematemesis, epistaxis, hemoptysis, hematochezia, metrorrhagia, puerperal lochia, and injury blood stasis.
Haw is sour and sweet in nature and slightly warm in taste. The meridians enter spleen, stomach and liver meridians. The functional indications are as follows: promoting digestion, removing blood stasis, expelling tapeworm. It is used to treat meat stagnation, abdominal mass, phlegm retention, distention and fullness, acid regurgitation, dysentery, intestinal wind, lumbago, hernia, puerperal infantile occipital pain, and infantile indigestion. Promote digestion, invigorate stomach, promote qi circulation and dissipate blood stasis. Can be used for treating dyspepsia, flatulence, dysentery, abdominal pain, blood stasis, amenorrhea, puerperal stagnation, heart and abdominal pain, hernia pain, and hyperlipidemia.
Purple perilla is pungent in property, warm in nature and taste, and has the effects of relieving exterior syndrome, dispelling cold, regulating qi and harmonizing nutrient. It can be used for treating common cold, fever, cough, asthma, and abdominal distention. Pungent and fragrant smell, slightly pungent taste. The tea is good for patients with large leaves, purple color, no branches and stalks and strong fragrance, and is suitable for treating wind-cold affection from the exterior, dampness stagnation in the interior and the symptoms of wind-cold invasion from the exterior and wind-cold dispersion from the lung, and spleen and blood circulation.
Ginkgo leaf astringes lung, relieves asthma, promotes blood circulation to remove blood stasis, and relieves pain. Can be used for treating cough and asthma due to lung deficiency; coronary heart disease, angina pectoris, hyperlipemia and anti-coagulation.
Alisma orientale is sweet in nature and cold in nature, enters kidney and bladder meridians, induces diuresis, excrets dampness and releases heat. It is used to treat dysuria, edema, emesis, dysentery, phlegm-fluid retention, tinea pedis, gonorrhea, and hematuria.
The invention has the beneficial effects that:
the invention provides a traditional Chinese medicine composition for reducing blood fat and a preparation method thereof, 6 natural traditional Chinese medicines of tartary buckwheat, lotus leaves, hawthorn, purple perilla, ginkgo leaves and rhizoma alismatis are reasonably compatible, the raw material components have good mutual synergistic effect, the absorption of cholesterol can be effectively reduced, the blood fat metabolism is regulated, the blood fat effect is obvious, the traditional Chinese medicine composition obtained by the invention does not contain any western medicine component, the medicine for long-term administration has low toxic and side effects, the source is wide, the cost is low, the cure rate is high, the drug resistance is not easy to generate, the preparation method is simple, the application prospect is wide, and the traditional Chinese medicine composition is suitable for wide popularization.
Detailed Description
The present invention is specifically described below with reference to examples in order to facilitate understanding of the present invention by those skilled in the art. It should be particularly noted that the examples are given solely for the purpose of illustration and are not to be construed as limitations on the scope of the invention, as non-essential improvements and modifications to the invention may occur to those skilled in the art, which fall within the scope of the invention as defined by the appended claims. Meanwhile, the raw materials mentioned below are not specified in detail and are all commercially available products; the process steps or extraction methods not mentioned in detail are all process steps or extraction methods known to the person skilled in the art.
Example 1
A traditional Chinese medicine composition comprises the following raw material components in parts by weight: 25 parts of tartary buckwheat, 10 parts of lotus leaves, 10 parts of hawthorn, 10 parts of purple perilla, 6 parts of ginkgo leaves and 9 parts of rhizoma alismatis.
The preparation method of the traditional Chinese medicine composition comprises the following steps: the preparation method comprises the following steps of taking 25 parts of tartary buckwheat, 10 parts of lotus leaves, 10 parts of hawthorn, 10 parts of perilla, 6 parts of ginkgo leaves and 9 parts of rhizoma alismatis according to parts by weight, mixing, adding water which is 8 times of the total amount of raw material components, soaking for 1 hour, soaking in an earthen pot, then decocting for 3 times, decocting for 20 minutes by adopting strong fire for the first time, decocting for 20 minutes for the rest two times by adopting slow fire, filtering, adding water which is 8 times of the total amount of the raw material components into filter residues, decocting for 30 minutes for the second time, adding water which is 8 times of the total amount of the raw material components into the filter residues after filtering, decocting for 30 minutes for the 3 rd time, combining the three decoctions, filtering, concentrating the filtrate into paste, drying, crushing and sieving to obtain the finished product 1 of the traditional Chinese medicine composition for reducing blood fat.
Example 2
A traditional Chinese medicine composition comprises the following raw material components in parts by weight: 35 parts of tartary buckwheat, 20 parts of lotus leaves, 20 parts of hawthorn, 15 parts of purple perilla, 8 parts of ginkgo leaves and 11 parts of rhizoma alismatis.
The preparation method of the traditional Chinese medicine composition comprises the following steps: the preparation method comprises the following steps of taking 35 parts of tartary buckwheat, 20 parts of lotus leaves, 20 parts of hawthorn, 15 parts of perilla, 8 parts of ginkgo leaves and 11 parts of rhizoma alismatis according to parts by weight, mixing, adding water which is 10 times of the total amount of raw material components, soaking for 1 hour, soaking in an earthen pot, then decocting for 3 times, decocting for 40 minutes by adopting strong fire for the first time, decocting for 40 minutes for the rest two times by adopting slow fire, filtering, adding water which is 10 times of the total amount of the raw material components into filter residues, decocting for 120 minutes for the second time, adding water which is 10 times of the total amount of the raw material components into the filter residues after filtering, decocting for 120 minutes for the 3 times, combining the three decoctions, filtering, concentrating the filtrate into paste, drying, crushing and sieving to obtain the finished product 2 of the traditional Chinese medicine composition for reducing blood fat.
Example 3
A traditional Chinese medicine composition comprises the following raw material components in parts by weight: 30 parts of tartary buckwheat, 15 parts of lotus leaves, 15 parts of hawthorn, 12.5 parts of purple perilla, 7 parts of ginkgo leaves and 10 parts of rhizoma alismatis.
The preparation method of the traditional Chinese medicine composition comprises the following steps: taking 30 parts of tartary buckwheat, 15 parts of lotus leaves, 15 parts of hawthorn, 12.5 parts of purple perilla, 7 parts of ginkgo leaves and 10 parts of rhizoma alismatis according to parts by weight, mixing, adding water 9 times of the total amount of the raw material components, soaking for 1 hour, soaking in a casserole, then decocting for 3 times, decocting for 30 minutes by adopting strong fire for the first time, decocting for 30 minutes by adopting slow fire for the rest two times, filtering, adding water 9 times of the total amount of the raw material components into filter residues, decocting for 75 minutes for the second time, adding water 9 times of the total amount of the raw material components into the filter residues after filtering, decocting for 75 minutes for the 3 rd time, combining the three decoctions, filtering, concentrating the filtrate into paste, drying, crushing and sieving to obtain the finished product 3 of the traditional Chinese medicine composition for reducing blood fat.
Comparative example 1
A traditional Chinese medicine composition comprises the following raw material components in parts by weight: 10 parts of lotus leaf, 10 parts of hawthorn, 10 parts of perilla and 9 parts of rhizoma alismatis.
The preparation method of the traditional Chinese medicine composition comprises the following steps: taking 10 parts of lotus leaves, 10 parts of hawthorn, 10 parts of purple perilla and 9 parts of rhizoma alismatis according to parts by weight, mixing, adding water which is 9 times of the total amount of the raw material components, soaking for 1 hour, soaking in an earthen pot, then decocting for 3 times, adopting strong fire for the first time, decocting for 30min, adopting slow fire for the rest two times of decoction, adding water which is 9 times of the total amount of the raw material components into filter residue after filtering, decocting for 75min for the second time, adding water which is 9 times of the total amount of the raw material components into the filter residue after filtering, decocting for 75min for the 3 rd time, combining the three decoctions, filtering, concentrating the filtrate into paste, drying, crushing and sieving to obtain the finished product 1 of the comparative traditional Chinese medicine composition for reducing blood fat.
Comparative example 2
A traditional Chinese medicine composition comprises the following raw material components in parts by weight: 15 parts of lotus leaf, 15 parts of hawthorn, 12.5 parts of purple perilla and 10 parts of rhizoma alismatis.
The preparation method of the traditional Chinese medicine composition comprises the following steps: taking 15 parts of lotus leaves, 15 parts of hawthorn, 12.5 parts of purple perilla and 10 parts of rhizoma alismatis according to parts by weight, mixing, adding water which is 9 times of the total amount of the raw material components, soaking for 1 hour, soaking in an earthen pot, then decocting for 3 times, adopting strong fire for the first time, decocting for 30min, adopting slow fire for the rest two times, adding water which is 9 times of the total amount of the raw material components into filter residues after filtering, decocting for 75min for the second time, adding water which is 9 times of the total amount of the raw material components into the filter residues after filtering, decocting for 75min for the 3 rd time, combining the three decoctions, filtering, concentrating the filtrate into paste, drying, crushing and sieving to obtain a finished product 2 of the comparative traditional Chinese medicine composition for reducing blood fat.
Clinical trial
250 patients with hyperlipidemia were randomly selected, and the basic symptoms were: obesity, skin yellow tumor, abdominal pain, limb debilitation pain. The male and female are not limited, the male and female are randomly divided into 5 groups, 50 people are taken in each group, the first group takes the finished traditional Chinese medicine composition product 1 for reducing blood fat of the embodiment 1, the second group takes the finished traditional Chinese medicine composition product 2 for reducing blood fat of the embodiment 2, the third group takes the finished traditional Chinese medicine composition product 3 for reducing blood fat of the embodiment 3, the first group takes the finished traditional Chinese medicine composition product 1 for reducing blood fat every morning, noon and evening, the first group takes the finished traditional Chinese medicine composition product 1 for reducing blood fat, the fifth group takes the finished traditional Chinese medicine composition product 2 for reducing blood fat, after 1 month, the number of effective, effective and ineffective patients is counted, the total effective rate (%) is calculated, and clinical symptoms are observed at the same time.
The curative effect standard is as follows: the method has the following advantages: the patients with hyperlipidemia gradually improve, and the blood pressure and blood lipid in vivo recover to normal values; secondly, the method is effective: the blood pressure and the blood fat in the body are obviously reduced; ③ invalid: blood pressure and blood lipid were not improved. The results are shown in table 1 below:
TABLE 1 test Effect of the finished products obtained in examples 1 to 3 and comparative examples 1 to 2, respectively, on hyperlipidemia patients
As can be seen from the treatment and the record in Table 1, the performance of the first three groups of finished Chinese medicinal composition products for reducing blood fat are obviously better than the comparative examples of the fourth group, and the symptoms of the first three groups of patients are improved to a certain extent. Therefore, the raw material components have good mutual synergistic effect, the absorption of cholesterol can be reduced effectively, the blood lipid metabolism is regulated, the blood lipid effect is obvious, the obtained traditional Chinese medicine composition does not contain any western medicine component, the toxic and side effects of the medicine after long-term administration are low, the source is wide, the cost is low, the cure rate is high, the medicine resistance is not easy to generate, the preparation method is simple, the application prospect is wide, and the traditional Chinese medicine composition is suitable for wide popularization.
It will be obvious to those skilled in the art that many simple derivations or substitutions can be made without inventive effort without departing from the inventive concept. Therefore, simple modifications to the present invention by those skilled in the art according to the present disclosure should be within the scope of the present invention. The above embodiments are preferred embodiments of the present invention, and all similar processes and equivalent variations to those of the present invention should fall within the scope of the present invention.
Claims (10)
1. The traditional Chinese medicine composition is characterized by comprising the following raw material components: tartary buckwheat, lotus leaves, hawthorn, purple perilla, ginkgo leaves and rhizoma alismatis.
2. The traditional Chinese medicine composition according to claim 1, which comprises the following raw material components in parts by weight: 20-40 parts of tartary buckwheat, 5-25 parts of lotus leaves, 5-25 parts of hawthorn, 5-20 parts of purple perilla, 5-10 parts of ginkgo leaves and 8-12 parts of rhizoma alismatis.
3. The traditional Chinese medicine composition according to claim 1, which comprises the following raw material components in parts by weight: 25-35 parts of tartary buckwheat, 10-20 parts of lotus leaves, 10-20 parts of hawthorn, 10-15 parts of purple perilla, 6-8 parts of ginkgo leaves and 9-11 parts of rhizoma alismatis.
4. The traditional Chinese medicine composition as claimed in claim 1, wherein the dosage form of the traditional Chinese medicine composition is any one of tablets, granules, capsules, pills, oral liquid or syrup.
5. The method for preparing the traditional Chinese medicine composition of any one of claims 1 to 4, which is characterized by comprising the following steps: mixing the raw material components, adding a solvent for soaking, decocting after soaking for 3 times, decocting with strong fire and slow fire, mixing decoctions, filtering, concentrating the filtrate into paste, and drying to obtain the traditional Chinese medicine composition.
6. The method according to claim 5, wherein the solvent is water.
7. The method of claim 5, wherein the decoction is carried out in an earthenware pot, an enamel pot or a stainless steel pot.
8. The method of claim 5, wherein the soaking time is 1-2 hours.
9. The preparation method according to claim 5, wherein the duration of the strong fire decoction is 20-40 min; decocting with slow fire for 30-120 min.
10. Use of the Chinese medicinal composition of any one of claims 1-4 in the preparation of a medicament for reducing blood lipid.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011577490.3A CN112618637A (en) | 2020-12-28 | 2020-12-28 | Traditional Chinese medicine composition for reducing blood fat and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011577490.3A CN112618637A (en) | 2020-12-28 | 2020-12-28 | Traditional Chinese medicine composition for reducing blood fat and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112618637A true CN112618637A (en) | 2021-04-09 |
Family
ID=75325985
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011577490.3A Withdrawn CN112618637A (en) | 2020-12-28 | 2020-12-28 | Traditional Chinese medicine composition for reducing blood fat and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112618637A (en) |
-
2020
- 2020-12-28 CN CN202011577490.3A patent/CN112618637A/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101011561B (en) | Modern traditional Chinese medicine oral preparation huanglianwendan decoction and production method thereof | |
| CN105995720A (en) | Enzyme Laiyang pear paste and preparation method and application thereof | |
| CN107029146A (en) | A kind of clearing lung and eliminating phlegm air making-up and spleen enlivening supports Chinese medicine composition of lung and preparation method thereof | |
| CN105708970B (en) | A kind of health food with function of blood sugar reduction | |
| CN105028772A (en) | Health care tea used for reducing blood fat and preparation method for health care tea | |
| CN106729190B (en) | A granule containing Chinese medicinal effective components for invigorating spleen, invigorating qi and eliminating dampness, and its preparation method | |
| CN112618637A (en) | Traditional Chinese medicine composition for reducing blood fat and preparation method thereof | |
| CN102362669A (en) | Rabdosiea Serrae Hara Guiling gel | |
| CN113144114A (en) | Traditional Chinese medicine composition for reducing blood fat and preparation method thereof | |
| CN102357151A (en) | Chinese medicinal composition for delaying senility and preparation process thereof | |
| NL2037306B1 (en) | A nutritional product for clearing and protecting the lungs and a preparation method thereof | |
| CN103520644B (en) | Traditional Chinese medicine composition used for treating phlegm stagnation type hyperlipidaemia and preparation method of composition | |
| CN112089783B (en) | Application of traditional Chinese medicine composition in preparation of medicine for preventing or/and treating obesity | |
| CN114712466B (en) | Medicine with weight-reducing and beautifying effects and preparation method thereof | |
| CN102626471A (en) | Traditional Chinese medicine composition with effects of anti-anaphylaxis, desensitization, repair and regeneration | |
| CN105457004A (en) | Orally-taken medicine for treating stomachaches caused by deficient cold of spleens and stomachs and preparation method thereof | |
| CN105125693A (en) | Traditional Chinese medicine composition for treating acute gastritis and preparing method thereof | |
| CN112494539A (en) | A Chinese medicinal composition for treating diabetes, and its preparation method | |
| CN104352763A (en) | Evergreen life-nourishing traditional Chinese medicinal wine and preparation method | |
| CN105362843A (en) | Medicine composition for treating spleen and stomach damp-heat type peptic ulcer and method for preparing medicine composition | |
| CN105169259A (en) | Prescription for treating manic-depressive psychosis and preparation method thereof | |
| CN112156159A (en) | Conditioning tablet and preparation method thereof | |
| CN118304366A (en) | Lipid-lowering traditional Chinese medicine composition and preparation method and application thereof | |
| CN114712470A (en) | Medicine for treating kidney deficiency of men and preparation method thereof | |
| CN117244028A (en) | Composition for alcoholic liver disease and preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20210409 |